IFN Regulatory Factor 8 Restricts the Size of the Marginal Zone and Follicular B Cell Pools
暂无分享,去创建一个
[1] S. Pillai,et al. The follicular versus marginal zone B lymphocyte cell fate decision , 2009, Nature Reviews Immunology.
[2] Chen-feng Qi,et al. IFN Regulatory Factor 8 Regulates MDM2 in Germinal Center B Cells1 , 2009, The Journal of Immunology.
[3] Hongsheng Wang,et al. IRF8 regulates myeloid and B lymphoid lineage diversification , 2009, Immunologic research.
[4] M. Raffeld,et al. Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments , 2009, Immunologic research.
[5] Chen-feng Qi,et al. IRF8 regulates B-cell lineage specification, commitment, and differentiation. , 2008, Blood.
[6] D. Roopenian,et al. NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas. , 2008, Cancer research.
[7] G. Gilkeson,et al. The Transcription Factor Fli-1 Modulates Marginal Zone and Follicular B Cell Development in Mice1 , 2008, The Journal of Immunology.
[8] P. Lipsky,et al. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein , 2008, Journal of Experimental Medicine.
[9] T. Taniguchi,et al. The IRF family transcription factors in immunity and oncogenesis. , 2008, Annual review of immunology.
[10] P. Tailor,et al. The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. , 2008, Blood.
[11] R. Lu,et al. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. , 2008, Blood.
[12] F. Weih,et al. Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen. , 2007, Blood.
[13] Lucia Gabriele,et al. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. , 2007, Immunity.
[14] D. Sgroi,et al. Synergism between NF-κB1/p50 and Notch2 during the Development of Marginal Zone B Lymphocytes1 , 2007, The Journal of Immunology.
[15] A. Iwama,et al. Mastermind-1 is required for Notch signal-dependent steps in lymphocyte development in vivo , 2007, Proceedings of the National Academy of Sciences.
[16] D. Sgroi,et al. Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes. , 2007, Journal of immunology.
[17] S. Akira,et al. Contribution of Receptor Editing to the Antibody Repertoire , 2007 .
[18] J. Monroe,et al. Analysis of the Individual Contributions of Igα (CD79a)- and Igβ (CD79b)-Mediated Tonic Signaling for Bone Marrow B Cell Development and Peripheral B Cell Maturation1 , 2006, The Journal of Immunology.
[19] R. Lu,et al. IFN Regulatory Factor 4 and 8 Promote Ig Light Chain κ Locus Activation in Pre-B Cell Development1 , 2006, The Journal of Immunology.
[20] M. Reth,et al. Testing gene function early in the B cell lineage in mb1-cre mice , 2006, Proceedings of the National Academy of Sciences.
[21] P. Lipsky,et al. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein , 2006, The Journal of experimental medicine.
[22] Li Wu,et al. The development of functional B lymphocytes in conditional PU.1 knock-out mice. , 2005, Blood.
[23] L. Garrett-Sinha,et al. Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. , 2005, International immunology.
[24] D. Malo,et al. A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia–like syndrome in BXH-2 mice , 2005, The Journal of experimental medicine.
[25] S. Pillai,et al. Marginal zone B cells. , 2005, Annual review of immunology.
[26] M. Nussenzweig,et al. Human Autoantibody Silencing by Immunoglobulin Light Chains , 2004, The Journal of experimental medicine.
[27] R. Pelanda,et al. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens , 2004, Nature Immunology.
[28] N. Tamaoki,et al. Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo , 2004, Nature Immunology.
[29] C. Murre,et al. Receptor Editing and Marginal Zone B Cell Development Are Regulated by the Helix-Loop-Helix Protein, E2A , 2004, The Journal of experimental medicine.
[30] C. S. Swindle,et al. Activated Notch2 Potentiates CD8 Lineage Maturation and Promotes the Selective Development of B1 B Cells , 2003, Molecular and Cellular Biology.
[31] Harinder Singh,et al. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. , 2003, Genes & development.
[32] S. Aizawa,et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. , 2003, Immunity.
[33] T. Honjo,et al. Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. , 2003, Immunity.
[34] S. Shinton,et al. Positive Selection of Anti–Thy-1 Autoreactive B-1 Cells and Natural Serum Autoantibody Production Independent from Bone Marrow B Cell Development , 2003, The Journal of experimental medicine.
[35] T. Manser,et al. Level of B Cell Antigen Receptor Surface Expression Influences Both Positive and Negative Selection of B Cells During Primary Development1 , 2002, The Journal of Immunology.
[36] S. Becker-Herman,et al. Id2 Negatively Regulates B Cell Differentiation in the Spleen1 , 2002, The Journal of Immunology.
[37] T. Honjo,et al. Notch–RBP-J signaling is involved in cell fate determination of marginal zone B cells , 2002, Nature Immunology.
[38] S. Shinton,et al. Resolution of Three Nonproliferative Immature Splenic B Cell Subsets Reveals Multiple Selection Points During Peripheral B Cell Maturation1 , 2001, The Journal of Immunology.
[39] W. Pear,et al. Ligand-independent Signaling Functions for the B Lymphocyte Antigen Receptor and Their Role in Positive Selection during B Lymphopoiesis , 2001, The Journal of experimental medicine.
[40] F. Weih,et al. Essential Role of RelB in Germinal Center and Marginal Zone Formation and Proper Expression of Homing Chemokines1 , 2001, The Journal of Immunology.
[41] Jian Ye,et al. A VH12 Transgenic Mouse Exhibits Defects in Pre-B Cell Development and Is Unable to Make IgM+ B Cells1 , 2001, The Journal of Immunology.
[42] S. Pillai,et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. , 2001, Immunity.
[43] K. Rajewsky,et al. Contribution of Receptor Editing to the Antibody Repertoire , 2001, Science.
[44] K. Ozato,et al. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. , 2000, Immunity.
[45] J. Silver,et al. Positive selection of natural autoreactive B cells. , 1999, Science.
[46] P. Sideras,et al. B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals , 1999, The Journal of experimental medicine.
[47] M. Retter,et al. Receptor Editing Occurs Frequently during Normal B Cell Development , 1998, The Journal of experimental medicine.
[48] B. Morgan,et al. Aiolos regulates B cell activation and maturation to effector state. , 1998, Immunity.
[49] K. Rajewsky,et al. In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death , 1997, Cell.
[50] J. Waring,et al. Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene , 1996, Cell.